Prevention of Cervical Cancer
Cervical cancer is the fourth most common cancer affecting women worldwide and the second commonest cancer affecting women in developing countries. In 2012 there were 530,000 new diagnoses (7.5% of all new cancer diagnoses in women) with 84% of these in resource-poor countries. In the same year, 270,000 women lost their lives to what is a preventable and treatable disease, and the overwhelming majority of these deaths were in women living in low- or middle-income countries.
Most cases of cervical cancer are attributable to infection with the human papillomavirus (HPV), with types 16 and 18 causing up to 70% of all cervical cancers and precancerous lesions. HPV is transmitted sexually. It is usually acquired soon after the onset of sexual activity and is therefore extremely common in men and women who are sexually active.
The World Health Organization strategy for the prevention of cervical cancer comprises primary, secondary, and tertiary prevention for women at different stages of their lives and in various stages of the natural history of the disease.
KeywordsCervix cancer Cervical cancer Primary prevention Secondary prevention Tertiary prevention HPV vaccine-Screening for cervical cancer Cervical malignancy
- 2.Ferlay J, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr
- 3.Human papilloma virus (HPV) and cervical cancer WHO Fact Sheet, Updated June 2016 http://www.who.int/mediacentre/factsheets/fs380/en/
- 9.FUTURE II Study Group. Quadrivalent vaccine against human papilloma virus to prevent high-grade cervical lesions. N Engl J Med. 2007;357:1915–27.Google Scholar
- 10.Centers for Disease Control and Prevention. Human papilloma virus (HPV) vaccine safety. CDC, 2015. www.cdc.gov/vaccinesafety/vaccines/hpv-vaccine.html
- 20.Martin-Hirsch P. Commentary on ‘Use of a high-risk human papilloma virus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study’. BJOG. 2013;120(10):1267–8.Google Scholar
- 22.World Health Organisation International Agency for Research on Cancer Screening Group. Visual Inspection with Acetic Acid: Evidence to Date. 2002. http://screening.iarc.fr/doc/RH_via_evidence.pdf. Accessed 11 June 2017.
- 26.World Health Organisation, Department of Reproductive Health and Research and Department of Chronic Diseases and Health Promotion, Geneva. Comprehensive cervical cancer control: a guide to essential practice (C4-GEP) 2006. http://www.who.int/reproductivehealth/publications/cancers/9241547006/en. Accessed 11 June 2017.
- 27.World Health Organisation. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. © World Health Organization 2013 ISBN 978 9241548694.Google Scholar
- 29.Cervical Cancer Incidence and Screening Coverage, NCRAS. http://www.ncin.org.uk/publications/data_briefings/cervical_incidence_and_screening
- 30.Cervical Cancer Mortality Statistics, Cancer Research UK. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer/mortality
- 31.World Health Organization: Global Atlas of Palliative Care at the End of Life, 2014. www.who.int/nmh/GlobalAtlasofPalliativeCare